Pharmaceutical companies often approve complex outsourcing contracts without fully understanding their commercial competitiveness, according to Nithin Mummaneni, founder and CEO of Infinity Loop. Mummaneni explains that different departments review contracts for their specific responsibilities, such as legal liability or regulatory compliance, but the overall cost implications and pricing terms can be overlooked. This lack of commercial benchmarking leaves procurement teams unaware if they are overpaying or missing opportunities for savings, especially given the increasing number of third-party vendors organizations work with. AI
RANK_REASON Opinion piece by a named credible voice discussing industry practices.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →